Ratings Manulife Financial Corporation Toronto S.E.

Equities

MFC.PR.N

CA56501R6766

Market Closed - Toronto S.E. Other stock markets 20:47:19 31/05/2024 BST			5-day change	1st Jan Change
21.36 ^CAD	+0.90%		+0.85%	+17.75%

05-24	Manulife Outlines Cash Distributions for Manulife ETFs	MT
05-23	TSX Down 24 Points at Midday, With Telecoms, Utilities, Lower	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

The company is in a robust financial situation considering its net cash and margin position.
The company's attractive earnings multiples are brought to light by a P/E ratio at 10.86 for the current year.
With regards to fundamentals, the enterprise value to sales ratio is at 0.92 for the current period. Therefore, the company is undervalued.
The company has a low valuation given the cash flows generated by its activity.
This company will be of major interest to investors in search of a high dividend stock.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Over the past four months, analysts' average price target has been revised upwards significantly.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

For the last few months, analysts have been revising downwards their earnings forecast.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
MANULIFE FINANCIAL CORPORATION	+17.75%	46.11B	-
AXA	+12.07%	78.95B	B-
METLIFE, INC.	+9.44%	50.57B	B+
AFLAC INCORPORATED	+8.93%	49.99B	B
PRUDENTIAL FINANCIAL, INC.	+16.04%	42.56B	B+
GENERALI	+23.53%	39.5B	B
GREAT-WEST LIFECO INC.	-6.79%	28.53B	B-
PRUDENTIAL PLC	-15.80%	26.19B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+22.84%	25.18B	A
DAI-ICHI LIFE HOLDINGS, INC.	+40.61%	24.98B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes